// App-Quantinova.ai

: Outcomes after Unrelated Cord Blood Transplantation (UCBT) in Patients with Chronic Myeloid Leukemia (CML): A Retrospective Study from the Cmwp-EBMT

Researchers

Presenter

  • Hugues De Lavallade

Principal Investigators

  • Linda Koster

  • Jaime Sanz

  • Emanuele Angelucci

  • Gerard Socie

  • Isabelle Pietri

  • Hlne Labussire-Wallet

  • Jan J Cornelissen

  • Tobias Gedde-Dahl

  • Eefke J. Petersen

  • Francesca Bonifazi

  • Jorge Sierra

  • Martin Carre

  • Tony Marchand

  • Cecile Pochon

  • Nigel H Russel

  • Victoria Potter

  • Henrik Sengeloev

  • Per Ljungman

  • Simona Lapusan

  • Didier Blaise

  • Anna Paola Iori

  • Annalisa Ruggeri

  • Yves Chalandon

  • Ibrahim Yakoub-Agha

Medical Centers

  • Department of Urology, King's College Hospital NHS Foundation Trust, London, United Kingdom

  • Gastroenterology Department, Kings College Hospital, London, United Kingdom

  • University of Rome Tor Vergata, Rome, Italy

  • EBMT Data Office Leiden,, Leiden,, Netherlands

  • Rheumatology Department, Hospital Universitari i Politecnic la Fe, Valencia, Spain

  • Hematology and Transplant Centre, Unita Operativa Ematologia Ospedale 'A. Businco', Genova, Italy

  • Bone-marrow transplantation department, CHU Saint-Louis, Paris, France

  • CHU Nice - Hôpital de l`ARCHET I, Nice, France

  • Service d'Hematologie, Centre Hospitalier, Lyon-Sud, France

  • Erasmus Medical Center Cancer Institute, Rotterdam, Netherlands

  • Oslo University Hospital, Oslo, Norway

  • Radiology, University Medical Center Utrecht, Utrecht

  • DIMES - Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology, University of Bologna, Bologna, Italy

  • Oncology Department, Hospital de la Santa Creu i Sant Pau and Universitat Autonoma de Barcelona, Barcelona, Spain

  • Department of Hematology, CHU-Grenoble Onco-Hematologie, Grenoble, France

  • CHU Rennes, Rennes, France

  • CHRU de Nancy - Université de Lorraine, NANCY, FRA

  • Nottingham Trent University, Nottingham, United Kingdom

  • King's College Hosptial NHS Foundation Trust, London, United Kingdom

  • Department of Hematology, University Hospital Rigshospitalet, Copenhagen, Denmark

  • Departments of Hematology and Cellular Therapy/Allogeneic Stem Cell Transplantation, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden

  • Hematology department, AP-HP, Hopital Saint Louis, Paris,

  • Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France

  • Hematology, Department of Cellular Biotechnologies and Hematology,Sapienza University of Rome-Azienda Policlinico Umberto I,Rome,Italy

  • Hospital Saint Antoine, Paris, France

  • Département d’Oncologie, Service d’Hématologie, Hôpitaux Universitaires de Genève, Geneva, Switzerland

  • Centre of Oncology, Geneva University Hospital, Geneva, Switzerland

  • CHU de Lille, LIRIC, INSERM U995, Université de Lille, France, Lille, France

Locations

  • United Kingdom

  • Italy

  • Netherlands

  • Spain

  • France

  • Norway

  • Denmark

  • Sweden

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Autoimmune (AI)

Disease

  • Chronic Myelogenous Leukemia

  • Graft-versus-host disease

Biomarkers

  • Breakpoint Cluster Region

  • Placental-specific protein 1

  • Soluble Complement 5b-9

Drug/Treatment

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved